|
METAP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.61720004054899E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.21350001953169E-09 |
| Normal-vs-Stage2 |
2.29929999999712E-05 |
| Normal-vs-Stage3 |
1.556800E-03 |
| Normal-vs-Stage4 |
9.051800E-02 |
| Stage1-vs-Stage2 |
7.698400E-01 |
| Stage1-vs-Stage3 |
1.132840E-01 |
| Stage1-vs-Stage4 |
9.979700E-02 |
| Stage2-vs-Stage3 |
1.342190E-01 |
| Stage2-vs-Stage4 |
1.012790E-01 |
| Stage3-vs-Stage4 |
5.805400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.62140309459369E-11 |
| Normal-vs-AfricanAmerican |
1.041690E-03 |
| Normal-vs-Asian |
7.876400E-02 |
| Caucasian-vs-AfricanAmerican |
2.354200E-02 |
| Caucasian-vs-Asian |
3.590200E-01 |
| AfricanAmerican-vs-Asian |
9.537800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.74635869601525E-12 |
| Normal-vs-Female |
3.043400E-03 |
| Male-vs-Female |
1.002510E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.3177999999866E-06 |
| Normal-vs-Extreme_Weight |
1.6581000017446E-08 |
| Normal-vs-Obese |
1.221780E-04 |
| Normal-vs-Extreme_Obese |
2.44709999999149E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.773800E-02 |
| Normal_Weight-vs-Obese |
5.199000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.361700E-02 |
| Extreme_Weight-vs-Obese |
8.564400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.570200E-01 |
| Obese-vs-Extreme_Obese |
6.304300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.543800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.82110000032954E-07 |
| Normal-vs-Age(61-80Yrs) |
6.85169698755317E-11 |
| Normal-vs-Age(81-100Yrs) |
1.157250E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.540160E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.372900E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.357000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.846300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.308200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.748800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.11389786283667E-11 |
| Normal-VS-Type2 PRCC |
1.93859999997326E-06 |
| Normal-VS-KIRP CIMP |
5.949600E-01 |
| Normal-VS-Unclassified PRCC |
2.210600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.989800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.007700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.867000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.513900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.046800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.482100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.53150003789904E-09 |
| Normal-vs-N1 |
2.433800E-01 |
| Normal-vs-N2 |
1.875810E-01 |
| N0-vs-N1 |
1.076500E-03 |
| N0-vs-N2 |
1.217800E-01 |
| N1-vs-N2 |
5.868000E-01 |
|
|
